Prostate Cancer Foundation (PCF) convened its 19th Annual Scientific Retreat October 25-27, 2012 in Carlsbad, CA.
Each year this event brings together diverse researchers in a collaborative forum to present and discuss new and largely unpublished findings for prostate cancer diagnosis, prognosis and treatment and defines the challenges to ending this disease as a threat to life and well-being. Several themes resonated at the multidisciplinary meeting, notably 1) the roles of field cancerization, tumor microenvironment, epithelial plasticity, signal transduction pathways in cancer progression and disease resistance, 2) intratumoral heterogeneity and consequences for precision medicine, 3) resistance mechanisms to androgen axis inhibitors, 4) advances in molecular imaging and therapeutics for better detection and treatment.
Written by:
Walia G, Pienta KJ, Simons JW, Soule HR. Are you the author?
Science, Prostate Cancer Foundation.
Reference: Cancer Res. 2013 Mar 27. Epub ahead of print.
doi: 10.1158/0008-5472.CAN-12-4576
PubMed Abstract
PMID: 23536559
UroToday.com Prostate Cancer Section
